HR-3032-119
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsored by Troy Balderson (R-OH)
What it does
This bill would require Medicare to pay for remote physiologic and remote therapeutic monitoring services when a provider collects at least 2 days of patient data within a 30-day period, down from the current 16-day minimum, for two years after enactment. It also requires the Secretary of Health and Human Services to consult with a wide range of medical and industry groups and submit a report to Congress within one year analyzing outcomes and recommending a longer-term reimbursement model based on patient acuity and monitoring duration.
Who benefits
Medicare beneficiaries who need shorter monitoring periods for conditions like sleep apnea, post-surgical recovery, hypertension, or physical therapy adherence; physicians, hospitals, and telehealth companies that provide remote monitoring services and could bill Medicare sooner and more often; remote monitoring device and technology manufacturers; and the Department of Veterans Affairs and other stakeholders whose input would shape future policy.
Who is hurt
Medicare's trust funds and taxpayers could bear increased costs if more monitoring episodes are billed at the same reimbursement rate for less data collected; CMS faces added administrative burden implementing a temporary rule change and producing the required report; and providers or intermediaries who built billing systems around the 16-day standard would need to adjust processes, potentially creating short-term compliance costs.
Supporters argue
Supporters argue the current 16-day requirement is clinically unnecessary for many conditions, citing examples like sleep apnea diagnosis, narcotic-related breathing monitoring, and post-surgical joint replacement tracking where fewer days of data provide clinically meaningful care. They point to a 2019 VA report showing a 53 percent decrease in bed days of care and a 33 percent decrease in hospital admissions among veterans using remote monitoring, arguing that lowering the threshold would expand access to a proven tool that improves outcomes and can reduce long-term costs.
Opponents argue
Opponents argue that lowering the minimum from 16 to 2 days without adjusting reimbursement rates could allow providers to bill full payments for substantially less monitoring, potentially increasing Medicare spending without proportional clinical benefit. They contend that CMS previously declined to make this change permanent because it had not received sufficient clinical evidence to justify differentiated reimbursement, and that a blanket 2-day rule for all conditions risks overpayment or reduced monitoring quality compared to a more tailored, condition-specific approach.
Constitutional context
Congress is exercising its Spending Clause authority (Art. I, §8, cl. 1) to set conditions on payments under the Medicare program, an area where Congress has broad discretion to define program eligibility and reimbursement rules; no landmark case constrains this type of routine program administration change.
Checks and balances
Congress directly sets the temporary payment rule in statute rather than delegating it to CMS rulemaking, and requires HHS to report back before any permanent change, preserving congressional oversight over the eventual reimbursement model.
Historical precedent
CMS itself temporarily lowered the monitoring threshold from 16 to 2 days for COVID-19 patients in the 2021 Physician Fee Schedule, and this bill would extend a similar temporary standard to all Medicare patients regardless of COVID-19 status.